Login
Search
Search
0 Dates
2024
2023
2022
2021
2020
2019
2018
0 Events
CPC 2018
CPC 2019
Curso de Atualização em Medicina Cardiovascular 2019
Reunião Anual Conjunta dos Grupos de Estudo de Cirurgia Cardíaca, Doenças Valvulares e Ecocardiografia da SPC
CPC 2020
CPC 2021
CPC 2022
CPC 2023
CPC 2024
0 Topics
A. Basics
B. Imaging
C. Arrhythmias and Device Therapy
D. Heart Failure
E. Coronary Artery Disease, Acute Coronary Syndromes, Acute Cardiac Care
F. Valvular, Myocardial, Pericardial, Pulmonary, Congenital Heart Disease
G. Aortic Disease, Peripheral Vascular Disease, Stroke
H. Interventional Cardiology and Cardiovascular Surgery
I. Hypertension
J. Preventive Cardiology
K. Cardiovascular Disease In Special Populations
L. Cardiovascular Pharmacology
M. Cardiovascular Nursing
N. E-Cardiology / Digital Health, Public Health, Health Economics, Research Methodology
O. Basic Science
P. Other
0 Themes
01. History of Cardiology
02. Clinical Skills
03. Imaging
04. Arrhythmias, General
05. Atrial Fibrillation
06. Supraventricular Tachycardia (non-AF)
07. Syncope and Bradycardia
08. Ventricular Arrhythmias and Sudden Cardiac Death (SCD)
09. Device Therapy
10. Chronic Heart Failure
11. Acute Heart Failure
12. Coronary Artery Disease (Chronic)
13. Acute Coronary Syndromes
14. Acute Cardiac Care
15. Valvular Heart Disease
16. Infective Endocarditis
17. Myocardial Disease
18. Pericardial Disease
19. Tumors of the Heart
20. Congenital Heart Disease and Pediatric Cardiology
21. Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure
22. Aortic Disease
23. Peripheral Vascular and Cerebrovascular Disease
24. Stroke
25. Interventional Cardiology
26. Cardiovascular Surgery
27. Hypertension
28. Risk Factors and Prevention
29. Rehabilitation and Sports Cardiology
30. Cardiovascular Disease in Special Populations
31. Pharmacology and Pharmacotherapy
32. Cardiovascular Nursing
33. e-Cardiology / Digital Health
34. Public Health and Health Economics
35. Research Methodology
36. Basic Science
37. Miscellanea
0 Resources
Abstract
Slides
Vídeo
Report
CLEAR FILTERS
Impact of lockdown measures during COVID-19 pandemic in activity level of patients with cardiac resynchronization therapy device: remote monitoring data from the TRIAGE-HF risk score
Session:
Posters - D. Heart Failure
Speaker:
Isabel Cardoso
Congress:
CPC 2021
Topic:
D. Heart Failure
Theme:
10. Chronic Heart Failure
Subtheme:
10.3 Chronic Heart Failure – Diagnostic Methods
Session Type:
Posters
FP Number:
---
Authors:
Isabel Gonçalves Machado Cardoso; Pedro Silva Cunha; Sérgio Laranjo; Guilherme Portugal; António Valentim; Madalena Cruz; João Reis; Ana Sofia Delgado; Bruno Valente; Rui Cruz Ferreira; Mário Oliveira
Abstract
<p><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><strong><span style="font-size:12.0pt"><span style="font-family:"Calibri",sans-serif">Introduction</span></span></strong></span></span></p> <p><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><span style="background-color:white"><span style="color:#222222">TRIAGE-HF risk score is a validated remote monitoring (RM) tool allowing integrated continuous physiological evaluation to risk-stratify patients (P) regarding heart failure (HF) decompensation events. Among other parameters, RM includes data from P activity (PA). A decreasing trend in PA, as a result of lockdown measures during COVID-19 outbreak, has been pointed out as a concern about the potential effects on cardiovascular risk.</span></span><strong> </strong></span></span></p> <p><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><strong><span style="font-size:12.0pt"><span style="font-family:"Calibri",sans-serif">Aims</span></span></strong></span></span></p> <p><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><span style="background-color:white"><span style="color:#222222">To evaluate the impact of lockdown measures during COVID-19 pandemic in activity levels of P with HF submitted to cardiac resynchronization therapy (CRT), followed via RM using the TRIAGE-HF risk score. </span></span><strong> </strong></span></span></p> <p><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><strong><span style="font-size:12.0pt"><span style="font-family:"Calibri",sans-serif">Methods </span></span></strong></span></span></p> <p><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><span style="background-color:white"><span style="color:#222222">HF P carrying CRT devices with Heart Failure Risk Status (HFRFS) algorithm available, and regular RM transmissions during the follow-up period were included. Three periods were considered: before lockdown (from January to 17<sup>th</sup> March 2020), during lockdown (18<sup>th</sup> of March to 2nd of May 2020) and after lockdown (3<sup>rd</sup> May to 14<sup>th</sup> of June). PA, measured by a single-axis accelerometer in the device, was analysed in all transmissions. HFRS algorithm which classifies the P </span></span>as low, medium or high risk was analysed. The relationship between the patients’ activity in the three different moments was assessed by ANOVA analysis. </span></span></p> <p><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><strong><span style="font-size:12.0pt"><span style="font-family:"Calibri",sans-serif">Results </span></span></strong></span></span></p> <p><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><span style="background-color:white"><span style="color:#222222">RM transmissions of 35P were assessed (71±10 years, 71.4% males, NYHA>II in 70%, left ventricular ejection fraction (LVEF) 28±7.8%). Post-CRT, LVEF was 52±7.21%, NT-proBNP 207±142 pg/mL, </span></span>NYHA class>II in 46%P); the responder rate was 85%<span style="background-color:white"><span style="color:#222222">. PA during the lockdown period declined from 2.8 hours/day to 1.9 hours/day, increasing to 2.3 hours/day in the post-lockdown period (p<0.001). After lockdown, </span></span>16P (46%) showed a persistent lower level of activity, compared to the pre-lockdown period. No significant differences were noted in the P HFRS during the 3 considered periods (pre-lockdown: low-risk 27%, medium-risk - 54%, high-risk - 19%; during lockdown: low-risk - 22%, medium-risk - 61%, high-risk - 17%; post-lockdown: low-risk - 34%,medium-risk - 51%, high-risk - 15%, p= 0.067) </span></span></p> <p><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><strong><span style="font-size:12.0pt"><span style="font-family:"Calibri",sans-serif">Conclusion </span></span></strong></span></span></p> <p><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><span style="background-color:white"><span style="color:#222222">Data obtained from the RM HFRS algorithm in P with CRT revealed a significant decline in physical activity during the lockdown period related to COVID-19 pandemic. Moreover, some P did not recover to the pre-lockdown levels of exercise, which may prompt </span></span>this population to future adverse HF outcomes.</span></span></p> <p> </p>
Slides
Our mission: To reduce the burden of cardiovascular disease
Visit our site